POLB and prostate cancer: As shown extensively in biochemical and cell studies (67), 30% of human tumors such as lung, gastric, colorectal, and prostate cancer express polβ variants carrying single amino acid substitutions, which lead to an aberrant activity in vitro such as a diminished gap filling activity (E295K).